Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Healthcare providers to join US plan to manage AI risks - White House

Published 12/14/2023, 09:03 AM
Updated 12/14/2023, 12:06 PM
© Reuters. Artificial Intelligence words are seen in this illustration taken March 31, 2023. REUTERS/Dado Ruvic/Illustration/File Photo

By Andrea Shalal

WASHINGTON (Reuters) - Twenty-eight healthcare companies, including CVS Health (NYSE:CVS) , are signing U.S. President Joe Biden's voluntary commitments aimed at ensuring the safe development of artificial intelligence (AI), a White House official said on Thursday.

The commitments by healthcare providers and payers follow those of 15 leading AI companies, including Google (NASDAQ:GOOGL), OpenAI and OpenAI partner Microsoft (NASDAQ:MSFT) to develop AI models responsibly.

Biden's government is pushing to set parameters around AI as it makes rapid gains in capability and popularity while regulation remains limited.

"The administration is pulling every lever it has to advance responsible AI in health-related fields," the White House official said, adding AI carried enormous potential to benefit patients, doctors and hospital staff, if managed responsibly.

Biden issued an executive order on Oct. 30 requiring developers of AI systems that pose risks to U.S. national security, the economy, public health or safety to share the results of safety tests with the government before releasing them to the public.

Providers signing the commitments include Oscar, Curai, Devoted Health, Duke Health, Emory Healthcare and WellSpan Health, the White House official said in a statement.

"We must remain vigilant to realize the promise of AI for improving health outcomes," the official said. "Without appropriate testing, risk mitigations and human oversight, AI-enabled tools used for clinical decisions can make errors that are costly at best - and dangerous at worst."

Absent proper oversight, diagnoses by AI can be biased by gender or race, especially when AI is not trained on data representing the population it is being used treat, the official said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The principles behind the administration plan call for companies to inform users whenever they receive content that is largely AI-generated and not reviewed or edited by people, and to monitor and address harms that applications might cause.

Companies that sign the commitments pledge to develop AI uses responsibly, including solutions that advance health equity, expand access to care, make care affordable, coordinate care to improve outcomes, reduce clinician burnout and otherwise improve the experience of patients.

Latest comments

binggo
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.